CN108783443A - 一种用于脏腑调理的片剂及其制备方法 - Google Patents
一种用于脏腑调理的片剂及其制备方法 Download PDFInfo
- Publication number
- CN108783443A CN108783443A CN201810643842.7A CN201810643842A CN108783443A CN 108783443 A CN108783443 A CN 108783443A CN 201810643842 A CN201810643842 A CN 201810643842A CN 108783443 A CN108783443 A CN 108783443A
- Authority
- CN
- China
- Prior art keywords
- parts
- powder
- tablet
- internal organs
- tabletting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000001835 viscera Anatomy 0.000 title claims abstract description 22
- 230000003750 conditioning effect Effects 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 79
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 34
- 244000068988 Glycine max Species 0.000 claims abstract description 32
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 32
- 241000209140 Triticum Species 0.000 claims abstract description 22
- 235000021307 Triticum Nutrition 0.000 claims abstract description 22
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 20
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 20
- 240000000171 Crataegus monogyna Species 0.000 claims abstract description 19
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 18
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 18
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 18
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 18
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 18
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 18
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 18
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 18
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 18
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 18
- 235000003145 Hippophae rhamnoides Nutrition 0.000 claims abstract description 18
- 235000001855 Portulaca oleracea Nutrition 0.000 claims abstract description 16
- 241001264174 Cordyceps militaris Species 0.000 claims abstract description 14
- 244000197580 Poria cocos Species 0.000 claims abstract description 14
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 14
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims abstract description 13
- 238000002156 mixing Methods 0.000 claims abstract description 13
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims abstract description 13
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims abstract description 11
- 238000001914 filtration Methods 0.000 claims abstract description 10
- 239000010903 husk Substances 0.000 claims abstract description 10
- 239000002994 raw material Substances 0.000 claims abstract description 10
- 240000000950 Hippophae rhamnoides Species 0.000 claims abstract description 9
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims abstract description 8
- 240000003582 Platycodon grandiflorus Species 0.000 claims abstract description 8
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 8
- 238000000605 extraction Methods 0.000 claims abstract description 8
- 238000001556 precipitation Methods 0.000 claims abstract description 7
- 238000003860 storage Methods 0.000 claims abstract description 7
- 238000012360 testing method Methods 0.000 claims abstract description 4
- 244000234609 Portulaca oleracea Species 0.000 claims abstract 4
- 235000019441 ethanol Nutrition 0.000 claims description 21
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 241000208671 Campanulaceae Species 0.000 claims description 7
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 7
- 244000126002 Ziziphus vulgaris Species 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 6
- 230000036541 health Effects 0.000 claims description 6
- 230000002829 reductive effect Effects 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 230000001681 protective effect Effects 0.000 claims description 4
- 238000010992 reflux Methods 0.000 claims description 4
- 102000004190 Enzymes Human genes 0.000 claims description 3
- 108090000790 Enzymes Proteins 0.000 claims description 3
- 108010068370 Glutens Proteins 0.000 claims description 3
- 102000057297 Pepsin A Human genes 0.000 claims description 3
- 108090000284 Pepsin A Proteins 0.000 claims description 3
- 238000003556 assay Methods 0.000 claims description 3
- 239000012141 concentrate Substances 0.000 claims description 3
- 229940088598 enzyme Drugs 0.000 claims description 3
- 235000021312 gluten Nutrition 0.000 claims description 3
- 238000000227 grinding Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 239000011812 mixed powder Substances 0.000 claims description 3
- 238000004806 packaging method and process Methods 0.000 claims description 3
- 229940111202 pepsin Drugs 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 239000007921 spray Substances 0.000 claims description 3
- 239000000758 substrate Substances 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 238000009461 vacuum packaging Methods 0.000 claims description 3
- 239000002023 wood Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 31
- 210000004369 blood Anatomy 0.000 abstract description 13
- 239000008280 blood Substances 0.000 abstract description 13
- 210000002784 stomach Anatomy 0.000 abstract description 12
- 210000004185 liver Anatomy 0.000 abstract description 11
- 210000004072 lung Anatomy 0.000 abstract description 11
- 206010011224 Cough Diseases 0.000 abstract description 9
- 210000000952 spleen Anatomy 0.000 abstract description 9
- 230000009286 beneficial effect Effects 0.000 abstract description 8
- 230000036039 immunity Effects 0.000 abstract description 8
- 241000894006 Bacteria Species 0.000 abstract description 7
- 210000003734 kidney Anatomy 0.000 abstract description 6
- 230000000968 intestinal effect Effects 0.000 abstract description 5
- 230000007413 intestinal health Effects 0.000 abstract description 4
- 238000012423 maintenance Methods 0.000 abstract description 4
- 238000005728 strengthening Methods 0.000 abstract description 4
- 101710146739 Enterotoxin Proteins 0.000 abstract description 3
- 238000004140 cleaning Methods 0.000 abstract description 3
- 239000000147 enterotoxin Substances 0.000 abstract description 3
- 231100000655 enterotoxin Toxicity 0.000 abstract description 3
- 238000001694 spray drying Methods 0.000 abstract 1
- 241000219304 Portulacaceae Species 0.000 description 12
- 239000003814 drug Substances 0.000 description 11
- 241000229143 Hippophae Species 0.000 description 9
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 9
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 206010010774 Constipation Diseases 0.000 description 7
- 210000003491 skin Anatomy 0.000 description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000005516 engineering process Methods 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 230000004224 protection Effects 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- 230000009102 absorption Effects 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000003712 anti-aging effect Effects 0.000 description 5
- 201000011510 cancer Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 210000000936 intestine Anatomy 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- 230000003078 antioxidant effect Effects 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- -1 lipid peroxide Chemical class 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 206010020772 Hypertension Diseases 0.000 description 3
- 235000003805 Musa ABB Group Nutrition 0.000 description 3
- 240000008790 Musa x paradisiaca Species 0.000 description 3
- 201000007100 Pharyngitis Diseases 0.000 description 3
- 235000015266 Plantago major Nutrition 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 241001247821 Ziziphus Species 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 235000012000 cholesterol Nutrition 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 208000014617 hemorrhoid Diseases 0.000 description 3
- 230000001976 improved effect Effects 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 208000024794 sputum Diseases 0.000 description 3
- 210000003802 sputum Anatomy 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 240000001592 Amaranthus caudatus Species 0.000 description 2
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 208000004232 Enteritis Diseases 0.000 description 2
- 208000018522 Gastrointestinal disease Diseases 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010027146 Melanoderma Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 244000170916 Paeonia officinalis Species 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 235000012735 amaranth Nutrition 0.000 description 2
- 239000004178 amaranth Substances 0.000 description 2
- 229930014669 anthocyanidin Natural products 0.000 description 2
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 2
- 235000008758 anthocyanidins Nutrition 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 208000029078 coronary artery disease Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 208000010643 digestive system disease Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 208000018685 gastrointestinal system disease Diseases 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000002218 hypoglycaemic effect Effects 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 206010022000 influenza Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 230000001151 other effect Effects 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010926 purge Methods 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 244000178993 Brassica juncea Species 0.000 description 1
- 235000011332 Brassica juncea Nutrition 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 201000006306 Cor pulmonale Diseases 0.000 description 1
- 235000008440 Crataegus cuneata Nutrition 0.000 description 1
- 244000160089 Crataegus cuneata Species 0.000 description 1
- 235000014283 Crataegus pinnatifida var major Nutrition 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000221079 Euphorbia <genus> Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 206010057178 Osteoarthropathies Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000756042 Polygonatum Species 0.000 description 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 208000004186 Pulmonary Heart Disease Diseases 0.000 description 1
- 206010061926 Purulence Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 241000607764 Shigella dysenteriae Species 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000002495 Uterine Neoplasms Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000002253 anti-ischaemic effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 230000001741 anti-phlogistic effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 239000000799 cathartic agent Substances 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 210000002391 femur head Anatomy 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 235000021384 green leafy vegetables Nutrition 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000027498 hoarse voice Diseases 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000026278 immune system disease Diseases 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 201000011061 large intestine cancer Diseases 0.000 description 1
- 150000002617 leukotrienes Chemical class 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 206010025135 lupus erythematosus Diseases 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000000242 pagocytic effect Effects 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000007180 physiological regulation Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 239000006041 probiotic Substances 0.000 description 1
- 230000000529 probiotic effect Effects 0.000 description 1
- 235000018291 probiotics Nutrition 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229940007046 shigella dysenteriae Drugs 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 229930182493 triterpene saponin Natural products 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 206010046766 uterine cancer Diseases 0.000 description 1
- 210000005167 vascular cell Anatomy 0.000 description 1
- 210000004509 vascular smooth muscle cell Anatomy 0.000 description 1
- 229940124549 vasodilator Drugs 0.000 description 1
- 239000003071 vasodilator agent Substances 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 description 1
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/50—Fermented pulses or legumes; Fermentation of pulses or legumes based on the addition of microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/09—Mashed or comminuted products, e.g. pulp, purée, sauce, or products made therefrom, e.g. snacks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明公开了一种用于脏腑调理的片剂及其制备方法,包括下述重量份的组份:黑豆马齿苋发酵粉20‑30份、沙棘粉20‑30份、圆包车前子壳15‑30份、红枣粉10‑25份、桔梗粉5‑10份、黄精粉30‑40份、山楂粉5‑10份、茯苓粉5‑10份、蛹虫草10‑20份、纳豆冻干粉30‑50份、水苏糖10‑20份、小麦低聚肽5‑10份。本发明还提出了一种用于脏腑调理的片剂的制备方法,包括原料预处理、混合提取、过滤醇沉、浓缩、压片、喷雾干燥、检验包装及检验入库等步骤。本发明能够清除宿便、清理肠道毒素、增加肠道有益菌、调节肠道健康、增强人体免疫力,具有减肥瘦身、养颜美容、健脾养胃、疏肝理气、养肝护肝、养心安神、补气养血、润肺止咳及养肾强身的功效。
Description
技术领域
本发明涉及片剂及其制备方法,特别涉及一种用于脏腑调理的片剂及其制备方法。
背景技术
经济和科技的高速发展给人类社会带来了巨大的变化,一方面,科技丰富了人们的生活、给人们带来了很多便利,另一方面,有些科技也对人们的身体健康造成了一些威胁。调理身体健康,仅靠平时的饮食注意是远远不够的。因此需要一种针对人体肝、心、脾、肺、肾五脏同时调理的产品。本产品中含有很多促进肠道健康、调理人体五脏的物质,如红枣、沙棘、茯苓、小麦肽、水苏糖、山楂等,这些物质具有清肠、排毒、通便、平衡内分泌系统、增强免疫力、活化细胞、美容养颜、控制体重等功效,将这些物质复合在一起制成片剂,能够有效调理身体素质。
发明内容
针对现有技术中的上述不足,本发明提供了一种用于脏腑调理的片剂及其制备方法,其效果好、无副作用。
为了达到上述发明目的,本发明采用的技术方案为:
一种用于脏腑调理的片剂,包括下述重量份的组份:黑豆马齿苋发酵粉20-30份、沙棘粉20-30份、圆包车前子壳15-30份、红枣粉10-25份、桔梗粉5-10份、黄精粉30-40份、山楂粉5-10份、茯苓粉5-10 份、蛹虫草10-20份、纳豆冻干粉30-50份、水苏糖10-20份、小麦低聚肽5-10份。
作为优选的,一种用于脏腑调理的片剂,包括下述重量份的组份:黑豆马齿苋发酵粉30份、沙棘粉 25份、圆包车前子壳20份、红枣粉15份、桔梗粉8份、黄精粉30份、山楂粉5份、茯苓粉5份、蛹虫草12份、纳豆冻干粉40份、水苏糖12份、小麦低聚肽5份。
一种用于脏腑调理的片剂的制备方法,包括如下步骤:
(1)原料预处理:分别挑选健康的沙棘、红枣、桔梗、黄精、山楂、茯苓、蛹虫草及圆包车前子壳,清水冲洗干净后一依次切片、烘干、研磨,制成原料粉;
(2)混合提取:按比例称取过30目筛的原料粉与黑豆马齿苋发酵粉、纳豆冻干粉、水苏糖、小麦低聚肽,混合均匀后加入一定量的乙醇,加热回流1-4h;
(3)过滤醇沉:加热的混合液经过过滤,在残渣内加入一定量的乙醇,再次加热回流1-4h,过滤,合并滤液,并减压回收乙醇;
(4)浓缩:滤液在60-70℃水浴挥干一段时间后,减压真空干燥12-48h,得到混合提取物;
(5)压片:混合提取物通过压片成型机,形成大小均匀的压片;
(6)喷雾干燥:压片经过喷雾干燥机后在表面形成保护膜,即为成品片剂;
(7)检验包装:对成品片剂进行检测,检测合格的成品片剂进入真空包装机进行真空包装;
(8)检验入库:包装后的片剂再次检验,检验合格后入库。
作为优选的,混合提取与过滤醇沉过程中所用的乙醇重量为混合粉的8-12倍,所用的乙醇浓度为80%。
作为优选的,所述小麦低聚肽由下述方法得到:
(1)将小麦蛋白配制成底物浓度为1%-5%的悬浮液,12mol/L HCl调节溶液的pH值至1-5;
(2)水浴至内部温度达到30-60℃,加入胃蛋白酶1000-2000U/g,保持pH值在±0.05之内,酶解 4-6h;
(3)到达酶解时间后,用10%NaOH调节pH至7.0使酶失活;
(4)水解液于2000-4000rpm离心10-20min,取上清液,浓缩干燥即得小麦肽。
本发明的有益效果为:
(1)清除宿便、清理肠道毒素,解决肠胃疾病、便秘、痔疮等问题;
(2)具有减肥瘦身的功效,能够加快身体的新陈代谢、阻止糖分和脂肪吸收,增加代谢速度与能量消耗;
(3)具有养颜美容的功效,能够有效去除脸部黑斑、青春痘各类问题;
(4)增加肠道有益菌,调节肠道健康,增强人体免疫力;
(5)具有健脾养胃、疏肝理气、养肝护肝、养心安神、补气养血、润肺止咳及养肾强身的功效。
具体实施方式
为了使本发明的内容更容易被清楚地理解,下面将对本发明实施例中的技术方案进行清楚、完整地描述。
沙棘:含有丰富的维生素C、β-胡萝卜素、黄酮类成分以及8种人体必需氨基酸,能够有效调节胃肠功能、保肝护肝、防止肝硬化、提高人体免疫力,有益于心脑血管疾病防治与肿瘤、癌症的预防;沙棘中含有大量氨基酸、有机酸等多种营养成分,可以促进胃酸的生物合成,刺激胃液分泌,因而具有消食化滞、健脾养胃、疏肝理气的作用;沙棘果实的汁对造血细胞有促进作用,其沙棘籽油口服对血小板聚集有抑制作用,同时中医也认为沙棘可以活血散淤,适用于跌打损伤、皮下出血以及女性月经不调有一定的调节作用;沙棘在传统医学理论中有止咳平喘、利肺化痰的作用,对慢性咽炎、支气管炎、哮喘、咳嗽多痰等呼吸道系统疾病均有很好作用;沙棘还可以降低血清总胆固醇,升高血清高密度脂蛋白胆固醇和肝脏总胆固醇,缓解心绞痛发作,对高脂血清损伤的血管平滑肌细胞有保护作用,能够明显的降低高脂损伤平滑肌细胞内增高的脂质过氧化物的含量,并能够明显升高超氧化物歧化酶的活性,能够减轻高脂血清对细胞膜的损伤,保护并促进细胞的健康生长,有明显的抗氧化作用。
红枣:性温味甘,含有蛋白质、多种氨基酸、胡萝卜素、维生素、铁、钙、磷物质,是补气养血的圣品,同时又物美价廉,民众无需购买民间昂贵的补品,善用红枣即可达到养生保健的功效。红枣具有美白祛斑、延缓衰老、补气养血、健脾益胃、补气养血、养血安神、缓和药性:红枣常被用于药性剧烈的药方中,以减少烈性药的副作用,并保护正气。如十枣汤中,用大枣缓解甘遂、大戟、芜花等泻药的毒性,保护脾胃不受伤害。
黄精:能够补肾与润肺生津,有抗缺氧、抗疲劳、抗衰老作用,能够增强免疫功能与新陈代谢,降血压、降血糖、降血脂,防止动脉粥样硬化,延缓衰老和抗菌等,黄精多糖具有免疫激活作用。黄精既补脾阴,又益脾气。
桔梗,主产于我国东北、华北、华东、华中各省,为药食两用品种,具有宣肺、利咽、祛痰、排脓等功效,常用于咳嗽痰多、胸闷不畅、咽痛、音哑、肺痈吐脓、疮疡脓成等病症。桔梗能够止咳祛痰、治疗失声、治疗肺痈、降低胆固醇;桔梗粗皂苷既有镇静、镇痛、解热作用,又能降血糖、降胆固醇,松弛平滑肌。桔梗中含有桔梗皂甙、维生素A、棕榈酸、亚麻酸等成分,其中大量的维生素C,治疗咳嗽痰多,无论寒热皆可以食用。桔梗辛散苦泻,开宣肺气,祛痰利咽,为治疗肺经气分病的重要药物。
蛹虫草:又叫北冬虫夏草、北虫草,蛹虫草的作用是治肾虚、阳萎遗精、腰膝酸痛、病后虚弱,中医认为其起扶正固本作用,对老年性慢性支气管炎、肺原性心脏病有显著疗效,能提高肝脏解毒能力,起护肝作用,提高身体抗病毒和抗辐射能力。经研究证明,蛹虫草具有调节全身功能、提高免疫能力、增强巨噬细胞的吞噬功能、促进抗体的形成,主要有保肺益肾养肝、止咳平喘祛痰、润肤防皱抗衰老、抗菌抗炎、镇静、扩张血管、降低血压、降低血糖、抗疲劳、耐缺氧等作用。
纳豆冻干粉:能够调整肠道菌群,抑制有害菌,保持有益菌占主导地位。改善胃炎、胃溃疡、肠炎、便秘、腹泻,肠易激综合症。抑制杀灭病菌病毒、预防感冒和流感;溶化血栓、修复受损的血液细胞、血管细胞,有效改善冠心病、高血压、动脉硬化、中风、静脉曲张;改善免疫系统,改善类风湿、红斑狼疮、牛皮癣等免疫系统疾病;促使癌细胞凋亡,改善息肉、增生、囊肿、肌瘤、肿瘤等;增加骨密度、改善骨质疏松症、股骨头坏死、骨关节病、痛风等疾病;修复胰岛细胞,改善糖尿病及并发症。肝功能障碍、老年痴呆等疾病;对活化大脑、提高记忆力和注意力、美容、减肥、防醉酒等都有很好的功效。
圆包车前子:传统疗用于治疗便秘、腹泻、痔疮、溃疡、膀胱毛病和高血压,现在也常用于抗皮肤刺激,包括常春藤毒性反应及昆虫叮咬。圆包车前子的种子是可利用的部份,能够润肠通便;可溶性圆苞车前子纤维具有降低血胆固醇的功效;圆苞车前子还可用于防止/治疗便秘或腹泻,它可充分吸收水分,增大体积至可排泄团块,增加肠道蠕动,减少粪便在肠内运送时间,并逐渐变得有规律;圆苞车前子纤维还发挥解毒剂的作用,有助于控制饭后的血糖上升,增加肠道的蠕动,减小对肠胃壁压力,还具有控制体重的功效。
茯苓:富含蛋白质、脂肪、维生素A、维生素E、微量元素等营养成分,其中维生素和微量元素,氨基酸,可以抑制癌细胞的产生,移除我们体内致癌的自由基等,可用来预防和治疗癌症。茯苓具有利水消肿、健脾止泻、养心安神的功效,对感冒也有一定的治愈效果;茯苓可影响体内代谢,对电解质的平衡有调解作用,并能降低血糖,抑制毛细血管的通透性;此外,茯苓多糖具有增强机体免疫功能与抗癌、抗肿瘤的作用,服用茯苓多糖可改善老年人的细胞免疫功能。
山楂:山里红或山楂的干燥成熟果实,山楂含有黄酮类、三萜皂苷类、皂苷类鞣质、脂肪酸、绿原酸、咖啡酸、维生素C、以及多种微量元素等,味酸甘、微温不热,有消食健胃、活血化淤、收敛止痢之功。山楂具有降血压、促进消化、降血脂、抗缺血、抗衰老、提高免疫力及防癌、抗癌的功效。山楂片所含的脂肪酸能促进脂肪类食物的消化,并能增加胃消化酶的分泌,且对肠胃功能有一定的调整作用;山楂富含钙、齐墩果酸、鸟素酸、山楂素等三萜类烯酸和黄酮类有益成分能舒张血管、加强和调节心肌,增大心室和心运动振幅及冠状动脉血流量,降低血清胆固醇和降低血压。故山楂是防治心血管病的理想保健食品和有较好疗效的食品,近来应用于高血压、高血脂、冠心病等的防治;山楂中含维生素C、维生素B、胡萝卜素及多种有机酸,口服能增加胃中消化酶的分泌,所含蛋白酶、脂肪酸,可促进肉食分解消化;山楂中含有的牡荆素等化合物具有抗癌作用,常用山楂有利于防癌。主要对子宫癌早期、大肠癌等,有很好的抗癌通淤作用;山楂中果胶含量居所有水果之首,果胶不仅具有防辐射的作用,还具有很好的吸附和抗菌的特性,可去除肠道细菌、毒素并束缚住水分,因此有助于帮助缓解腹泻。
黑豆马齿苋发酵粉:采用中科院多种益生菌联合发酵高新技术开发生产,以黑豆及马齿苋为基料,采用低温干燥及灭活技术,获得高浓缩活性酵素粉。
黑豆又名乌豆,内含丰富的蛋白质、多种矿物质和微量元素。黑豆对年轻女性来说,还有美容养颜的功效。古代药典上曾记载黑豆可驻颜、明目、乌发,使皮肤白嫩等。黑豆皮为黑色,含有花青素,花青素是很好的抗氧化剂来源,能清除体内自由基,尤其是在胃的酸性环境下,抗氧化效果好,养颜美容,增加肠胃蠕动。黑豆中含有丰富的维生素E、VE也是一种抗氧化剂,能清除体内自由基,减少皮肤皱纹,保持青春健美。黑豆中粗纤维含量高达4%,常食黑豆可提供食物中的粗纤维,促进消化,防止便秘发生。
马齿苋又名长寿菜、长命菜、马齿菜、马踏菜等,因“其叶比并如马齿,而性滑利似苋”(叶子形状像马齿,气味像苋莱)而得名,中医认为,马齿苋作为一位中药材性寒,味甘酸,入心、肝、脾、大肠经,中医经常将其用药作为清热解毒、消肿止痛、治疗肠炎腹泻等症。马齿苋对大肠杆菌、痢疾杆菌等多种细菌的生长和存活有很强的抑制作用,能有效地治疗腹泻,是“天然抗生素”。
水苏糖:可以有效防止并缓解婴幼儿便秘及腹泻,抑制肠道疾病;可以全面增强婴幼儿的免疫能力,提高婴幼儿的机体抗病力;此外,水苏糖具有清肠道,排毒排铅的效果,还可以置换金属离子,从而促进钙等矿物质吸收。
小麦低聚肽:低聚肽是近年来最重要的生物科技成果之一。低聚肽是由2-6个氨基酸构成的片段,分子量在1000Dalton以下,达到了不需消化或稍加消化就可以吸收的程度。可以说,低聚肽是预消化的蛋白质,可直接吸收,不增加胃肠道的消化负担,特别适合胃肠功能减弱的人群食用。低聚肽安全、可放心食用,溶解性好、对酸热稳定,吸收速度快、程度高、起效快,而且低聚肽跟蛋白质一样是营养物质,但比蛋白质更易消化,吸收利用率更高,营养作用更强。低聚肽是分子量很小的片段,并且能够以肽的形式直接吸收,在体内可以表现出多个方面的生理调节功能,如缓解体力疲劳、增强免疫力、抗氧化、保护胃肠粘膜、保护肝脏、改善皮肤等。所以,吃低聚肽,是一举两得或一举多得。
一种用于脏腑调理的片剂,包括下述重量份的组份:黑豆马齿苋发酵粉20-30份、沙棘粉20-30份、圆包车前子壳15-30份、红枣粉10-25份、桔梗粉5-10份、黄精粉30-40份、山楂粉5-10份、茯苓粉5-10 份、蛹虫草10-20份、纳豆冻干粉30-50份、水苏糖10-20份、小麦低聚肽5-10份。
具体实施例一:
一种用于脏腑调理的片剂,包括下述重量份的组份:黑豆马齿苋发酵粉30份、沙棘粉25份、圆包车前子壳20份、红枣粉15份、桔梗粉8份、黄精粉30份、山楂粉5份、茯苓粉5份、蛹虫草12份、纳豆冻干粉40份、水苏糖12份、小麦低聚肽5份。
具体实施例二:
一种用于脏腑调理的片剂,包括下述重量份的组份:黑豆马齿苋发酵粉25份、沙棘粉25份、圆包车前子壳30份、红枣粉20份、桔梗粉8份、黄精粉30份、山楂粉8份、茯苓粉8份、蛹虫草15份、纳豆冻干粉50份、水苏糖15份、小麦低聚肽8份。
一种用于脏腑调理的片剂的制备方法,包括如下步骤:
(1)原料预处理:分别挑选健康的沙棘、红枣、桔梗、黄精、山楂、茯苓、蛹虫草及圆包车前子壳,清水冲洗干净后一依次切片、烘干、研磨,制成原料粉;
(2)混合提取:按比例称取过30目筛的原料粉与黑豆马齿苋发酵粉、纳豆冻干粉、水苏糖、小麦低聚肽,混合均匀后加入一定量的乙醇,加热回流1-4h;
(3)过滤醇沉:加热的混合液经过过滤,在残渣内加入一定量的乙醇,再次加热回流1-4h,过滤,合并滤液,并减压回收乙醇;
(4)浓缩:滤液在60-70℃水浴挥干一段时间后,减压真空干燥12-48h,得到混合提取物;
(5)压片:混合提取物通过压片成型机,形成大小均匀的压片;
(6)喷雾干燥:压片经过喷雾干燥机后在表面形成保护膜,即为成品片剂;
(7)检验包装:对成品片剂进行检测,检测合格的成品片剂进入真空包装机进行真空包装;
(8)检验入库:包装后的片剂再次检验,检验合格后入库。
作为优选的,混合提取与过滤醇沉过程中所用的乙醇重量为混合粉的8-12倍,所用的乙醇浓度为80%。
作为优选的,所述小麦低聚肽由下述方法得到:
(1)将小麦蛋白配制成底物浓度为1%-5%的悬浮液,12mol/L HCl调节溶液的pH值至1-5;
(2)水浴至内部温度达到30-60℃,加入胃蛋白酶1000-2000U/g,保持pH值在±0.05之内,酶解4-6h;
(3)到达酶解时间后,用10%NaOH调节pH至7.0使酶失活;
(4)水解液于2000-4000rpm离心10-20min,取上清液,浓缩干燥即得小麦肽。
本发明所述的一种用于脏腑调理的片剂,适用人群广,以上午或晚上服用为好,使用时使用温开水送服,使用后多喝温开水。
服用本发明时,应避免与其他化学类药品同时食用,在症状改善后可以逐渐减少使用量。
本发明的有益效果为:
(1)清除宿便、清理肠道毒素,解决肠胃疾病、便秘、痔疮等问题;
(2)具有减肥瘦身的功效,能够加快身体的新陈代谢、阻止糖分和脂肪吸收,增加代谢速度与能量消耗;
(3)具有养颜美容的功效,能够有效去除脸部黑斑、青春痘各类问题;
(4)增加肠道有益菌,调节肠道健康,增强人体免疫力;
(5)具有健脾养胃、疏肝理气、养肝护肝、养心安神、补气养血、润肺止咳及养肾强身的功效。
以上所述仅为本发明专利的较佳实施例而已,并不用以限制本发明专利,凡在本发明专利的精神和原则之内所作的任何修改、等同替换和改进等,均应包含在本发明专利的保护范围之内。
Claims (5)
1.一种用于脏腑调理的片剂,其特征在于,包括下述重量份的组份:黑豆马齿苋发酵粉20-30份、沙棘粉20-30份、圆包车前子壳15-30份、红枣粉10-25份、桔梗粉5-10份、黄精粉30-40份、山楂粉5-10份、茯苓粉5-10份、蛹虫草10-20份、纳豆冻干粉30-50份、水苏糖10-20份、小麦低聚肽5-10份。
2.根据权利要求1所述的一种用于脏腑调理的片剂,其特征在于:包括下述重量份的组份:黑豆马齿苋发酵粉30份、沙棘粉25份、圆包车前子壳20份、红枣粉15份、桔梗粉8份、黄精粉30份、山楂粉5份、茯苓粉5份、蛹虫草12份、纳豆冻干粉40份、水苏糖12份、小麦低聚肽5份。
3.一种用于脏腑调理的片剂的制备方法,其特征在于,应用如权利要求1-2所述的一种用于脏腑调理的片剂,包括如下步骤:
(1)原料预处理:分别挑选健康的沙棘、红枣、桔梗、黄精、山楂、茯苓、蛹虫草及圆包车前子壳,清水冲洗干净后一依次切片、烘干、研磨,制成原料粉;
(2)混合提取:按比例称取过30目筛的原料粉与黑豆马齿苋发酵粉、纳豆冻干粉、水苏糖、小麦低聚肽,混合均匀后加入一定量的乙醇,加热回流1-4h;
(3)过滤醇沉:加热的混合液经过过滤,在残渣内加入一定量的乙醇,再次加热回流1-4h,过滤,合并滤液,并减压回收乙醇;
(4)浓缩:滤液在60-70℃水浴挥干一段时间后,减压真空干燥12-48h,得到混合提取物;
(5)压片:混合提取物通过压片成型机,形成大小均匀的压片;
(6)喷雾干燥:压片经过喷雾干燥机后在表面形成保护膜,即为成品片剂;
(7)检验包装:对成品片剂进行检测,检测合格的成品片剂进入真空包装机进行真空包装;
(8)检验入库:包装后的片剂再次检验,检验合格后入库。
4.根据权利要求3所述的一种用于脏腑调理的片剂的制备方法,其特征在于:混合提取与过滤醇沉过程中所用的乙醇重量为混合粉的8-12倍,所用的乙醇浓度为80%。
5.根据权利要求3所述的一种用于脏腑调理的片剂的制备方法,其特征在于:所述小麦低聚肽由下述方法得到:
(1)将小麦蛋白配制成底物浓度为1%-5%的悬浮液,12mol/L HCl调节溶液的pH值至1-5;
(2)水浴至内部温度达到30-60℃,加入胃蛋白酶1000-2000U/g,保持pH值在±0.05之内,酶解4-6h;
(3)到达酶解时间后,用10%NaOH调节pH至7.0使酶失活;
(4)水解液于2000-4000rpm离心10-20min,取上清液,浓缩干燥即得小麦肽。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810643842.7A CN108783443A (zh) | 2018-06-21 | 2018-06-21 | 一种用于脏腑调理的片剂及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810643842.7A CN108783443A (zh) | 2018-06-21 | 2018-06-21 | 一种用于脏腑调理的片剂及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108783443A true CN108783443A (zh) | 2018-11-13 |
Family
ID=64084229
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810643842.7A Pending CN108783443A (zh) | 2018-06-21 | 2018-06-21 | 一种用于脏腑调理的片剂及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108783443A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112841536A (zh) * | 2021-02-01 | 2021-05-28 | 武汉海奥圣医疗科技股份有限公司 | 一种新型纳豆多肽保健食品及其制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103320293A (zh) * | 2013-07-10 | 2013-09-25 | 杜明华 | 一种中药保健酒配方及制备方法 |
CN105385532A (zh) * | 2015-12-21 | 2016-03-09 | 江苏力酒酒业有限公司 | 一种含有蛹虫草螺旋藻植物组合物力酒的制备方法 |
CN105768055A (zh) * | 2016-04-11 | 2016-07-20 | 中科和素(天津)医药科技有限公司 | 一种用于调理肠道的营养制剂及其制备方法 |
-
2018
- 2018-06-21 CN CN201810643842.7A patent/CN108783443A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103320293A (zh) * | 2013-07-10 | 2013-09-25 | 杜明华 | 一种中药保健酒配方及制备方法 |
CN105385532A (zh) * | 2015-12-21 | 2016-03-09 | 江苏力酒酒业有限公司 | 一种含有蛹虫草螺旋藻植物组合物力酒的制备方法 |
CN105768055A (zh) * | 2016-04-11 | 2016-07-20 | 中科和素(天津)医药科技有限公司 | 一种用于调理肠道的营养制剂及其制备方法 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112841536A (zh) * | 2021-02-01 | 2021-05-28 | 武汉海奥圣医疗科技股份有限公司 | 一种新型纳豆多肽保健食品及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN106722963A (zh) | 一种素食餐 | |
CN109123643A (zh) | 一种谷物代餐球的制备方法 | |
CN108651806A (zh) | 一种全营养膳食纤维固体饮料及其制备方法 | |
CN103478796A (zh) | 一种野生菌汤料的配方及生产方法 | |
CN107029146A (zh) | 一种清肺化痰补气健脾养肺的中药组合物及其制备方法 | |
CN109550040A (zh) | 一种增强免疫力的中药多肽组合物 | |
CN106072527A (zh) | 一种排毒养颜的纳豆组方及其制备方法 | |
CN105768070A (zh) | 一种调理肠胃的功能性营养食品 | |
CN106937741A (zh) | 一种脱脂亚麻籽粉防癌抗癌健康减肥法及其制备方法 | |
CN107897908A (zh) | 一种适用于减肥瘦身的早餐冲调食疗组合物及其制备方法 | |
CN103877122A (zh) | 中药阿胶原料的生产方法及其产品 | |
CN103652926A (zh) | 肿瘤病人食品组合物 | |
CN104479964A (zh) | 一种黄秋葵、菌、藻保健酒及其制备方法 | |
CN102511876B (zh) | 山楂红枣浓浆及其生产工艺 | |
CN105861252A (zh) | 一种灵芝保健米酒 | |
CN110214902A (zh) | 一种儿童纠正偏食型富硒全营养粉 | |
CN108783443A (zh) | 一种用于脏腑调理的片剂及其制备方法 | |
CN109730222A (zh) | 酵素复合液及其保健饮料 | |
CN109527577A (zh) | 一种具有解酒护肝功能的组合物 | |
CN109043325A (zh) | 一种食用复合菌粉 | |
CN107594526A (zh) | 一种海藻胶为囊材的助消化软胶囊制剂的制备方法 | |
CN107125751A (zh) | 龟粉、制备方法及其应用 | |
CN104031805B (zh) | 一种秋季调和养生酒及其制备方法 | |
CN103689561A (zh) | 一种有助于降脂减肥的养生保健食品配方及其制备方法 | |
KR101093006B1 (ko) | 미생물을 이용한 우황 청심원 원료 함유 건강식품의 제조방법 및 그 제조방법에 의해 제조된 건강식품 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181113 |
|
RJ01 | Rejection of invention patent application after publication |